Search Results for "Epigallocatechin 3-gallate" - 61 interactions found in 11 entries.

Entry-ID
Interactor1 (Subject) Interaction type Interactor2 (Object) additional information
PubMed-ID
Diseases
924
5595 Epigallocatechin 3-gallate decreases_quantity of Amyloid beta peptide in primary neurons; derived from Swedish mutant APP-overexpressing mice TgAPPswl line 2576
5598 Epigallocatechin 3-gallate decreases_activity of amyloidosis in primary neurons; derived from Swedish mutant APP-overexpressing mice TgAPPswl line 2576
5600 Epigallocatechin 3-gallate decreases_activity of Alzheimer disease in primary neurons; derived from Swedish mutant APP-overexpressing mice TgAPPswl line 2576
5661 Epigallocatechin 3-gallate increases_processing of APP at alpha-C-terminal fragment of APP
5665 Epigallocatechin 3-gallate decreases_quantity of amyloid beta deposits in Tg APPsw transgenic mice overproducing Abeta
5730 Epigallocatechin 3-gallate increases_quantity of sAPP-alpha
5732 Epigallocatechin 3-gallate increases_activity of Alpha-secretase
28097 Epigallocatechin 3-gallate increases_quantity of APP (CTF-alpha)
16177050 Alzheimer disease
933
5643 Epigallocatechin 3-gallate affects_quantity of Amyloid beta peptide in murine neuron-like cells (N2a)
16177050 Alzheimer disease
937
5733 Epigallocatechin 3-gallate increases_quantity of ADAM10 (active) in SweAPPN2a cells
16624814 Alzheimer disease
1,581
11383 Epigallocatechin 3-gallate decreases_quantity of CXCL8 in intestine
18377686 Diabetes mellitus, type II
Insulin resistance
1,586
11426 Epigallocatechin 3-gallate decreases_activity of Insulin resistance in high-fat-fed mice
11427 Epigallocatechin 3-gallate decreases_quantity of Cholesterol in blood; in high-fat-fed mice
11428 Epigallocatechin 3-gallate decreases_quantity of CCL2 in high-fat-fed mice
11429 Epigallocatechin 3-gallate decreases_quantity of liver in high-fat-fed mice
11430 Epigallocatechin 3-gallate decreases_quantity of Triacylglycerol in liver; in high-fat-fed mice
11431 Epigallocatechin 3-gallate decreases_quantity of GPT in liver; in high-fat-fed mice
11483 Epigallocatechin 3-gallate decreases_activity of Fatty liver disease, nonalcoholic
11484 Epigallocatechin 3-gallate decreases_activity of Obesity
11485 Epigallocatechin 3-gallate decreases_activity of Metabolic syndrome
18716169 Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
Metabolic syndrome
1,591
11493 Epigallocatechin 3-gallate decreases_quantity of Reactive oxygen species
11494 Epigallocatechin 3-gallate decreases_activity of response to oxidative stress
11496 Epigallocatechin 3-gallate decreases_activity of COMT in vitro and in vivo
11500 Epigallocatechin 3-gallate increases_quantity of 3,4-Dihydroxy-L-phenylalanine in vitro and in vivo by inhibiting COMT
11505 Epigallocatechin 3-gallate decreases_activity of neuron death if neuron death has been induced by kainic acid
11506 Epigallocatechin 3-gallate increases_activity of neuroprotection
11525 Epigallocatechin 3-gallate decreases_activity of Parkinson disease
20700524 Parkinson disease
1,592
11513 Epigallocatechin 3-gallate decreases_quantity of IL6 in inflamed cells
11514 Epigallocatechin 3-gallate decreases_quantity of CXCL8 in inflamed cells
11517 Epigallocatechin 3-gallate decreases_activity of inflammatory response
11554 Epigallocatechin 3-gallate decreases_expression of TNFRSF1A
11562 Epigallocatechin 3-gallate decreases_expression of STAT3
11563 Epigallocatechin 3-gallate decreases_expression of SREBF1
11564 Epigallocatechin 3-gallate decreases_expression of CYP1A1
11565 Epigallocatechin 3-gallate decreases_expression of FASN
11588 Epigallocatechin 3-gallate decreases_expression of IL1B in inflamed cells
11589 Epigallocatechin 3-gallate decreases_expression of PTGS1 in inflamed cells
20816778 Diabetes mellitus, type II
Insulin resistance
1,598
11668 Epigallocatechin 3-gallate decreases_activity of inflammatory response in peritoneal macrophages; after LPS treatment
11669 Epigallocatechin 3-gallate decreases_expression of TNF in peritoneal macrophages; after LPS treatment
11670 Epigallocatechin 3-gallate decreases_expression of IL6 in peritoneal macrophages; after LPS treatment
11671 Epigallocatechin 3-gallate decreases_quantity of NO in peritoneal macrophages; after LPS treatment
11672 RPSA increases_activity of Epigallocatechin 3-gallate in peritoneal macrophages
11689 Epigallocatechin 3-gallate decreases_expression of TLR4 via RPSA
11725 Epigallocatechin 3-gallate decreases_activity of Lipopolysaccharide in macrophages; via RPSA
11726 Epigallocatechin 3-gallate decreases_activity of stress-activated MAPK cascade in macrophages; via RPSA
11727 Epigallocatechin 3-gallate decreases_activity of NF-kappaB complex in macrophages; after LPS activation via RPSA
11777 Epigallocatechin 3-gallate decreases_expression of TLR4 in macrophages; via RPSA
11778 Epigallocatechin 3-gallate increases_expression of TOLLIP in macrophages; via RPSA
11779 Epigallocatechin 3-gallate decreases_activity of toll-like receptor 4 signaling pathway in macrophages; via RPSA
20511545 Diabetes mellitus, type II
Insulin resistance
5,036
49680 Epigallocatechin 3-gallate decreases_expression of OLR1
49681 Epigallocatechin 3-gallate decreases_quantity of Reactive oxygen species induced by oxLDL
49688 Epigallocatechin 3-gallate decreases_quantity of OLR1
20203069 Cardiovascular disease
Atherosclerosis
5,185
50774 Epigallocatechin 3-gallate decreases_activity of amyloidosis in Tg2576 mice
50808 Epigallocatechin 3-gallate decreases_quantity of amyloid beta deposits via converting large mature Abeta fibrils into smaller nontoxic aggregates;
50874 Epigallocatechin 3-gallate increases_activity of cognition in Tg2576 mice
21982844 Alzheimer disease
Dementia
Tauopathy
6,536
62154 Epigallocatechin 3-gallate decreases_activity of enlarged heart left atrium
62155 Epigallocatechin 3-gallate decreases_activity of restricted left ventricle
62156 Epigallocatechin 3-gallate decreases_activity of isovolumetric relaxation time
62157 Epigallocatechin 3-gallate interacts (colocalizes) with TNNC1
62159 Epigallocatechin 3-gallate decreases_activity of diastolic dysfunction
62161 Epigallocatechin 3-gallate increases_activity of calcium desensitization
25813360 Cardiomyopathy, familial restrictive
-->